Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3126-3131

  Ge, Shu Hua ^a   Wan, Zhe ^b   Li, Juan ^a,c   Xu, Jianping ^a,d   Li, Ruo Yu ^b   Bai, Feng Yan ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHINA; ERG11 GENE; FUNGAL GENE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; MISSENSE MUTATION; MOUTH CAVITY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VULVOVAGINITIS;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; FUNGAL PROTEINS; GENOTYPE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 77955405525     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00118-10     Document Type: Article

References (27)

1. Antonopoulou, S., M. Aoun, E. C. Alexopoulos, S. Baka, E. Logothetis, T. Kalambokas, A. Zannos, K. Papadias, O. Grigoriou, E. Kouskouni, and A. Velegraki. 2009. Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes. Antimicrob. Agents Chemother. 53:2181-2184.
2. Arzeni, D., M. Del Poeta, O. Simonnetti, A. M. Offidani, L. Lamura, M. Balducci, N. Cester, A. Giacometti, and G. Scalise. 1997. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. Eur. J. Epidemiol. 13:447-450.
3. Chong, P. P., Y. L. Lee, B. C. Tan, and K. P. Ng. 2003. Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia. J. Med. Microbiol. 52:657-666.
4. Chong, P. P., S. R. Abdul Hadi, Y. L. Lee, C. L. Phan, B. C. Tan, K. P. Ng, and H. F. Seow. 2007. Genotyping and drug resistance profile of Candida spp. in recurrent and one-off vaginitis, and high association of non-albicans species with non-pregnant status. Infect. Genet. Evol. 7:449-456.
5. Coste, A., A. Selmecki, A. Forche, D. Diogo, M. E. Bougnoux, C. d'Enfert, J. Berman, and D. Sanglard. 2007. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot. Cell 6:1889-1904.
6. El-Din, S. S., M. T. Reynolds, H. R. Ashbee, R. C. Barton, and E. G. V. Evans. 2001. An investigation into the pathogenesis of vulvovaginal candidosis. Sex. Transm. Infect. 77:179-183.
7. Eschenbach, D. A. 2004. Chronic vulvovaginal candidiasis. N. Engl. J. Med. 351:851-852.
8. Fan, S. R., Q. P. Liao, J. Li, X. P. Liu, Z. H. Liu, and F. Y. Bai. 2008. Genotype distribution of Candida albicans strains associated with different conditions of vulvovaginal candidiasis, as revealed by microsatellite typing. Sex. Transm. Infect. 84:103-106.
9. Jiang, W. S., S. S. Tan, G. Y. Jiang, and Q. X. Chen. 2006. Synergistic effect of terbinafine combined with fluconazole or itraconazole on stable fluconazole-resistant Candida albicans induced by fluconazole in vitro. Chin. J. Microbiol. Immunol. 26:360-364.
10. Lee, M.-K., L. E. Williams, D. W. Warnock, and B. A. Arthington-Skaggs. 2004. Drug resistance genes and trailing growth in Candida albicans isolates. J. Antimicrob. Chemother. 53:217-224.
11. Li, J., S. R. Fan, X. P. Liu, D. M. Li, Z. H. Nie, F. Li, H. Lin, W. M. Huang, L. L. Zong, J. G. Jin, H. Lei, and F. Y. Bai. 2008. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China. Clin. Infect. Dis. 47:1119-1125.
12. Lian, C., J. Zhao, Z. Zhang, and W. Liu. 2004. Genotype of Candida species associated with different conditions of vulvovaginal candidosis. Mycoses 47: 495-502.
13. Liu, X. P., S. R. Fan, F. Y. Bai, J. Li, and Q. P. Liao. 2009. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis. Mycoses 52:24-28.
14. Lynch, M. E., and J. D. Sobel. 1994. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J. Med. Vet. Mycol. 32:267-274.
15. Mathema, B., E. Cross, E. Dun, S. Park, J. Bedell, B. Slade, M. Williams, L. Riley, V. Chaturvedi, and D. S. Perlin. 2001. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals. Clin. Infect. Dis. 33:e23-e27.
16. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. NCCLS, Wayne, PA.
17. Ribeiro, M. A., R. Dietze, C. R. Paula, D. A. Da Matta, and A. L. Colombo. 2001. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia 151:5-10.
18. Richter, S. S., R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 43: 2155-2162.
19. Sampaio, P., L. Gusmão, C. Alves, C. Pina-Vaz, A. Amorim, and C. Pais. 2003. Highly polymorphic microsatellite for identification of Candida albicans strains. J. Clin. Microbiol. 41:552-557.
20. Saporiti, A. M., D. Gómez, S. Levalle, M. Galeano, G. Davel, W. Vivot, and L. Rodero. 2001. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev. Argent. Microbiol. 33:217-222.
21. Sobel, J. D. 2007. Vulvovaginal candidosis. Lancet 369:1961-1971.
22. Sobel, J. D., S. Faro, R. W. Force, B. Foxman, W. J. Ledger, P. R. Nyirjesy, B. D. Reed, and P. R. Summers. 1998. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapy considerations. Am. J. Obstet. Gynecol. 178: 203-211.
23. Sobel, J. D., H. C. Wiesenfeld, M. Martens, P. Danna, T. M. Hooton, A. Rompalo, M. Sperling, C. Livengood III, B. Horowitz, J. V. Thron, L. Edwards, H. Panzer, and T.-C. Chu. 2004. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N. Engl. J. Med. 351:876-883.
24. Sojakova, M., D. Liptajova, M. Borovsky, and J. Subik. 2004. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 157:163-169. (Pubitemid 38463749)
25. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
26. White, T. C. 1997. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14-alphademethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1488-1494.
27. Xu, Y., L. Chen, and C. Li. 2008. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. J. Antimicrob. Chemother. 61:798-804.